FCN2 and hepatocellular carcinoma: However, previous studies have also shown that FCN2 and MBL can be used as biomarkers for the progression of chronic HCV infection to hepatocellular carcinoma, especially when the conversion from HCV to HCC is followed by a significant increase in FCN2 expression (Jalal et al., 2019).